Actively Recruiting
Clinical Trial of TQB3002 in Patients With Advanced Cancers
Led by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Updated on 2025-11-25
150
Participants Needed
11
Research Sites
94 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase I study to evaluate the safety, tolerability, and efficacy of TQB3002 in subjects with advanced cancers
CONDITIONS
Official Title
Clinical Trial of TQB3002 in Patients With Advanced Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntarily agree to join the study, sign consent, and comply with study requirements
- Age 18 years or older
- ECOG performance status of 0 or 1
- Expected survival longer than 3 months
- Histologically or cytologically confirmed advanced cancer
- Have failed standard therapy or lack effective treatment options
- Major organs functioning well
- Agree to use contraception during the study and for 6 months after if of childbearing potential
You will not qualify if you...
- Presence of other cancers within 5 years before first dose
- Any unresolved toxicity above mild (CTCAE Grade 1) from previous anti-tumor therapy
- Major surgery, biopsy, or significant injury within 4 weeks before first dose
- Long-term unhealed wounds or fractures
- Stroke, deep vein thrombosis, or pulmonary embolism within 6 months before first dose
- Swallowing problems, active gastrointestinal diseases, or prior major stomach surgery
- History of psychotropic drug abuse or mental disorder
- Any severe or uncontrolled disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China, 510180
Actively Recruiting
2
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, Guangdong, China, 518117
Not Yet Recruiting
3
Henan Cancer Hospital
Zhengzhou, Henan, China, 450003
Not Yet Recruiting
4
Jiangsu Province Hospital
Nanjing, Jiangsu, China, 210029
Not Yet Recruiting
5
The First Affiliated Hospital Of Nanchang University
Nanchang, Jiangxi, China, 330038
Not Yet Recruiting
6
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China, 200000
Not Yet Recruiting
7
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China, 710004
Not Yet Recruiting
8
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi’an, Shanxi, China, 710061
Not Yet Recruiting
9
Sichuan Cancer Hospital
Chengdu, Sichuan, China, 610040
Not Yet Recruiting
10
Mianyang Central Hospital
Mianyang, Sichuan, China, 621099
Not Yet Recruiting
11
Yunnan Cancer Hospital
Kunming, Yunnan, China, 650118
Not Yet Recruiting
Research Team
Q
Qing Zhou, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here